Definitive Contract HDTRA116C0061
- Not listed
- This is a $1,271,417.59 Cost Plus Fixed Fee contract awarded by the Defense Threat Reduction Agency (DTRA), a defense agency, to Genecapture, Inc., a for-profit startup company. The contract is for a Small Business Technology Transfer (STTR) Phase II effort focused on developing infectious disease diagnostics and differentiation of viral versus bacterial infections for point-of-care applications. The contract was set aside for small businesses. Genecapture specializes in rapid infectious disease...
- Genecapture, Inc. was awarded a $999,752.38 definitive cost-plus-fixed-fee contract by the Defense Threat Reduction Agency to continue research and development efforts initiated under Phase I of the Small Business Innovation Research program. The contract will support the company's work to deliver infectious disease diagnostics and differentiate between viral and bacterial infections for point-of-care applications, advancing the agency's goals of protecting the United States from weapons of mass...
- The Defense Health Agency (DHA) awarded a $249,938.77 Small Business Innovation Research (SBIR) Phase I contract to Genecapture, Inc., a for-profit startup company located at the Hudson Alpha Institute for Biotechnology. The contract is for the project titled "Expanding Genecapture's Rapid Portable Invasive Fungal Infection (IFI) Diagnostics for Wound Infections." Genecapture develops rapid infectious disease detection solutions using their patented CAPTURE technology, which identifies...
- This federal contract award was made by the Department of the Army Medical Command to Genecapture, Inc., a for-profit startup company, under the Small Business Innovation Research (SBIR) program. The contract, valued at $249,959.25, is for Phase I feasibility research on Genecapture's CAPTURE technology, which enables rapid identification of genetic signatures of pathogens for infectious disease detection and diagnosis. The award has a total small business set-aside designation. Genecapture...
- The Department of the Air Force Materiel Command Research Laboratory awarded a $284,827 Other Transaction Agreement to Genecapture, Inc., a for-profit small business startup, to research and develop a ruggedized and upgraded version of a commercially available pathogen detector that can be deployed in forward environments. This award is not set aside for any specific business type. Genecapture has received prior Small Business Innovation Research (SBIR) Phase II contracts from the Army,...
- Genecapture, Inc. was awarded a definitive contract valued at $1,099,956.91 by the Department of the Army Medical Command to conduct research and development under the Small Business Innovation Research (SBIR) Program Phase II. The contract supports Proposal No. H2-0647 titled "Genecapture's Fieldable Diagnostic Platform for Rapid ID and AST of Wound Pathogens." Research will be conducted in Huntsville, Alabama over a period of performance from September 2021 through January 2024 under...
- This federal contract award, HDTRA117P0016, was issued by the Defense Threat Reduction Agency (DTRA) to Reference Genomics, Inc., a small business contractor, for a Small Business Innovation Research (SBIR) Phase I research project. The $149,871.00 firm fixed-price contract was awarded on March 21, 2017, with an ultimate completion date of October 20, 2017. The contract was set aside for total small business participation. This SBIR Phase I award supports research and development activities...
- This is a $149,877.00 firm fixed price purchase order awarded by the Defense Threat Reduction Agency (DTRA) to Radiant Genomics, Inc., a small disadvantaged business. The contract is for a SBIR Phase I research project. SBIR stands for Small Business Innovation Research, which is a program that provides funding for small businesses to conduct research and development. The contract has a total small business set-aside, meaning it was reserved for small businesses. The period of performance ends...
- This is a $147,976.50 firm fixed-price purchase order awarded by the Defense Threat Reduction Agency (DTRA) to Daktari Diagnostics, Inc., a self-certified small disadvantaged business, for a SBIR Phase I research project. The contract is set aside for small businesses. The work will be performed in Cambridge, MA and the ultimate completion date is October 10, 2017. This SBIR Phase I contract is part of DTRA's broader SBIR program, which provides funding to small businesses for research and...
- <p>This federal contract award, with ID HDTRA116P0048, was issued by the Defense Threat Reduction Agency (DTRA) to Paratus Diagnostics, LLC, a small business contractor. The $149,394.07 firm fixed-price contract is for a SBIR (Small Business Innovation Research) Phase I research project. The contract was awarded on August 29, 2016, with a period of performance through August 31, 2017. The contract has a "Total Small Business" set-aside designation.</p>
This is a Small Business Technology Transfer (STTR) Phase I contract awarded by the Defense Threat Reduction Agency (DTRA) to Genecapture, Inc., a for-profit startup company. The $150,523.52 firm-fixed-price contract is for the development of infectious disease diagnostics and differentiation of viral vs. bacterial infections for point-of-care applications. Genecapture specializes in rapid pathogen detection solutions using their patented CAPTURE technology. This contract supports DTRA's efforts to improve diagnostic capabilities for infectious diseases in military medical settings, from forward-deployed locations to point-of-care. Genecapture has received multiple SBIR and STTR awards from various defense agencies for projects focused on developing fieldable diagnostic platforms for rapid identification and antibiotic susceptibility testing of pathogens.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $150.5k | 9/20/16 |